Presumed histoplasmic maculopathy: clinical course and prognosis in nonphotocoagulated eyes.
In this chapter, we have tried to identify some of the variables related to the visual prognosis in eyes with presumed histoplasmic maculopathy. We are cognizant that a constellation of other as yet unidentifiable variables also may play a role in the visual prognosis. Also, we have reported our visual results in patients who were nt photocoagulated. Many of these patients received corticosteroid therapy in some form, but we found it impossible to compare treatment ot nontreatment groups. Our results for visual prognosis is all nonphotocoagulated eyes are in general agreement with those available in the literature. For instance, Gass et al. [1] report 20 of 38 eyes (52.6 percent) with visual acuity of 20/200 or less. Also, this same study documents retention of 20/30 or better central vision in 13 of 38 eyes (34 percent), and the visual results in our study for all 54 nonphotocoagulated eyes parallel the reported findings of Schlaegel et al. [3] where 59 percent of eyes ended with a visual acuity of 20/200 or worse, 30 percent with vision of 20/50 or better, and 18 percent with vision of 20/30 or better...
D005584:Fovea Centralis; D006660:Histoplasmosis / Q000150:complications / Q000473:pathology; D006801:Humans; D008266:Macula Lutea; D008566:Membranes / Q000473:pathology; D011379:Prognosis; D012008:Recurrence; D012075:Remission, Spontaneous; D012164:Retinal Diseases / Q000150:complications / Q000473:pathology; D012166:Retinal Hemorrhage / Q000209:etiology; D012171:Retinal Vessels; D012189:Retrospective Studies; D012306:Risk; D014786:Vision Disorders / Q000209:etiology